Lansoprazole Pellets
Enteric-coated lansoprazole pellets providing rapid acid control with low ash content for clean compression runs.
Product overview
Lansoprazole EC Pellets – Enteric-Coated PPI Pellets for Reliable Delayed-Release Formulations. Rraynex Lansoprazole Pellets are developed for pharmaceutical manufacturers producing delayed-release oral dosage forms. Controlled pelletization, seal coating, and enteric protection are used to provide consistent pellet characteristics and gastro-resistant performance suitable for capsule filling and multiparticulate formulations. Overview: Lansoprazole is a proton pump inhibitor used in acid-related gastrointestinal therapies. Its acid-labile nature makes controlled enteric protection an important part of pellet formulation. Rraynex processes Lansoprazole Pellets with controlled particle size, coating, moisture, and dissolution characteristics to support reliable downstream manufacturing. Key Features & Benefits: • Enteric-coated delayed-release platform. • Uniform pellet morphology for capsule filling. • Controlled coating for gastro-resistance. • Suitable for MUPS and multiparticulate development. • Bulk pharmaceutical supply for formulation and commercial programs. SEO Content: Rraynex supplies Lansoprazole Pellets, Lansoprazole EC Pellets, Lansoprazole Delayed Release Pellets, Lansoprazole Enteric Coated Pellets, Lansoprazole Gastro Resistant Pellets, Lansoprazole Pellet Manufacturer, Lansoprazole Pellet Supplier, Lansoprazole Manufacturer India, Bulk Lansoprazole Pellets, Proton Pump Inhibitor Pellets, PPI Pellets Manufacturer, Pharmaceutical Pellets Manufacturer, Capsule Filling Pellets, MUPS Pellets, Multiparticulate Pellets, Bulk Pharmaceutical Pellets, Pharmaceutical Exporter, CDMO and Contract Manufacturing solutions.
Technical & formulation advantages
- Controlled pelletization and coating for reproducible dissolution and downstream handling.
- Uniform particle size and morphology suitable for capsule filling and multiparticulate systems.
- Manufactured under WHO-GMP with in-process controls on assay, moisture and related substances.
- Technical support for formulation development, scale-up and regulatory documentation.
Technical specifications are available upon request.
Applications
- Capsule filling and multiparticulate dosage forms (including MUPS where applicable).
- Pharmaceutical formulation and commercial manufacturing for Anti-Ulcerant (Ppls) therapies.
- CDMO and contract manufacturing programs requiring bulk lansoprazole pellets.
Bulk pharmaceutical supply & commercial manufacture
Rraynex operates as a pharmaceutical pellets manufacturer and supplier based in India, supporting bulk supply, export and contract manufacturing for Lansoprazole Pellets. Supply is available in standard 25/50 kg packaging with batch traceability. Export documentation, DMF/COA access procedures and stability information are provided on request for applicable products.
Contact Rraynex for bulk pellet supply • View manufacturing capabilities
Bulk pharmaceutical supply & product enquiries
Looking to source Lansoprazole Pellets in bulk? Rraynex supports pharmaceutical companies seeking Lansoprazole Pellets for formulation development, capsule filling and commercial pharmaceutical manufacturing. Buyers can request product specifications, available strengths, technical documentation, samples where applicable, commercial quotations and bulk supply information.
- product specifications
- available strengths
- technical documentation
- samples where applicable
- commercial quotations
- bulk supply information
B2B supply only — not a consumer pharmacy. Pricing available on request for bulk quantities.
Related capabilities
Related products
Technical specifications
- Grade
- IP / BP / USP / EP
- Type
- Pellets
- Category
- Anti-Ulcerant (Ppls)
- Pack size
- 25/50 kg
- Available strengths
- 8.5%, 12.5%, 30%
- Certifications
- WHO-GMP, ISO 9001, ISO 14001
Only use specification terms supported by existing product data. Additional technical documentation is available upon request.